SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ian Clark, Hans Peter Landolt, Coffee, caffeine, and sleep: A systematic review of epidemiological studies and randomized controlled trials, Sleep Medicine Reviews, 2016,

    CrossRef

  2. 2
    Gail D. Anderson, Lingtak-Neander Chan, Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products, Clinical Pharmacokinetics, 2016,

    CrossRef

  3. 3
    Lars Peter Holst Andersen, Ismail Gögenur, Jacob Rosenberg, Russel J. Reiter, Pharmacokinetics of Melatonin: The Missing Link in Clinical Efficacy?, Clinical Pharmacokinetics, 2016,

    CrossRef

  4. 4
    Lars P. H. Andersen, Mads U. Werner, Mette M. Rosenkilde, Nathja G. Harpsøe, Hanne Fuglsang, Jacob Rosenberg, Ismail Gögenur, Pharmacokinetics of oral and intravenous melatonin in healthy volunteers, BMC Pharmacology and Toxicology, 2016, 17, 1

    CrossRef

  5. 5
    Laurence Gabriel, Michel Tod, Sylvain Goutelle, Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers, Clinical Pharmacokinetics, 2016,

    CrossRef

  6. 6
    Sebastian C. Holst, Amandine Valomon, Hans-Peter Landolt, Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy, Annual Review of Pharmacology and Toxicology, 2016, 56, 1, 577

    CrossRef

  7. 7
    Lars Peter Holst Andersen, Ismail Gögenur, Jacob Rosenberg, Russel J. Reiter, The Safety of Melatonin in Humans, Clinical Drug Investigation, 2016, 36, 3, 169

    CrossRef

  8. 8
    Nathja Groth Harpsøe, Lars Peter Holst Andersen, Ismail Gögenur, Jacob Rosenberg, Clinical pharmacokinetics of melatonin: a systematic review, European Journal of Clinical Pharmacology, 2015, 71, 8, 901

    CrossRef

  9. 9
    David J Kennaway, Potential safety issues in the use of the hormone melatonin in paediatrics, Journal of Paediatrics and Child Health, 2015, 51, 6
  10. 10
    S. B. Brown, S. E. Hankinson, A. H. Eliassen, K. W. Reeves, J. Qian, K. F. Arcaro, L. R. Wegrzyn, W. C. Willett, E. S. Schernhammer, Urinary Melatonin Concentration and the Risk of Breast Cancer in Nurses' Health Study II, American Journal of Epidemiology, 2015, 181, 3, 155

    CrossRef

  11. 11
    Daniel Cardinali, Daniel Vigo, Natividad Olivar, María Vidal, Luis Brusco, Melatonin Therapy in Patients with Alzheimer’s Disease, Antioxidants, 2014, 3, 2, 245

    CrossRef

  12. 12
    Eleni Papagiannidou, Debra J. Skene, Costas Ioannides, Potential drug interactions with melatonin, Physiology & Behavior, 2014, 131, 17

    CrossRef

  13. 13
    Fatmah A.M. Al-Omary, Profiles of Drug Substances, Excipients, and Related Methodology, 2013,

    CrossRef

  14. 14
    Ronald G. Reichert, Textbook of Natural Medicine, 2013,

    CrossRef

  15. 15
    Natasa Dragicevic, Vedad Delic, Chuanhai Cao, Neil Copes, Xiaoyang Lin, Maggie Mamcarz, Li Wang, Gary W. Arendash, Patrick C. Bradshaw, Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells, Neuropharmacology, 2012, 63, 8, 1368

    CrossRef

  16. 16
    Shu-Feng Zhou, Bo Wang, Li-Ping Yang, Jun-Ping Liu, Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2, Drug Metabolism Reviews, 2010, 42, 2, 268

    CrossRef

  17. 17
    Shu-Feng Zhou, Jun-Ping Liu, Balram Chowbay, Polymorphism of human cytochrome P450 enzymes and its clinical impact, Drug Metabolism Reviews, 2009, 41, 2, 89

    CrossRef

  18. 18
    Karen T. Hallam, Denovan P. Begg, James S. Olver, Trevor R. Norman, An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers, Human Psychopharmacology: Clinical and Experimental, 2008, 23, 2
  19. 19
    Sophia L. Markantonis, Eleftheria Tsakalozou, Anteia Paraskeva, Chryssoula Staikou, Argyro Fassoulaki, Melatonin Pharmacokinetics in Premenopausal and Postmenopausal Healthy Female Volunteers, The Journal of Clinical Pharmacology, 2008, 48, 2
  20. 20
    R Bourne, Pharmacokinetics of oral melatonin in patients recovering from critical illness, Critical Care, 2008, 12, Suppl 2, P511

    CrossRef

  21. 21
    Johanna Hilli, Tuomas Korhonen, Miia Turpeinen, Juho Hokkanen, Sampo Mattila, Kari Laine, The Effect of Oral Contraceptives on the Pharmacokinetics of Melatonin in Healthy Subjects With CYP1A2 g.-163C>A Polymorphism, The Journal of Clinical Pharmacology, 2008, 48, 8
  22. 22
    E. S. Schernhammer, F. Berrino, V. Krogh, G. Secreto, A. Micheli, E. Venturelli, S. Sieri, C. T. Sempos, A. Cavalleri, H. J. Schunemann, S. Strano, P. Muti, Urinary 6-Sulfatoxymelatonin Levels and Risk of Breast Cancer in Postmenopausal Women, JNCI Journal of the National Cancer Institute, 2008, 100, 12, 898

    CrossRef

  23. 23
    Todd MacKenzie, Richard Comi, Patrick Sluss, Ronit Keisari, Simone Manwar, Janice Kim, Robin Larson, John A. Baron, Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial, Metabolism, 2007, 56, 12, 1694

    CrossRef

  24. 24
    Dun-Xian Tan, Lucien C. Manchester, Maria P. Terron, Luis J. Flores, Russel J. Reiter, One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?, Journal of Pineal Research, 2007, 42, 1
  25. 25
    Seithikurippu R Pandi-Perumal, Venkatramanujan Srinivasan, D Warren Spence, Daniel P Cardinali, Role of the Melatonin System in the Control of Sleep, CNS Drugs, 2007, 21, 12, 995

    CrossRef

  26. 26
    Sebastian Härtter, Tuomas Korhonen, Stefan Lundgren, Anders Rane, Ari Tolonen, Miia Turpeinen, Kari Laine, Effect of Caffeine Intake 12 or 24 Hours Prior to Melatonin Intake and CYP1A2*1F Polymorphism on CYP1A2 Phenotyping by Melatonin, Basic & Clinical Pharmacology & Toxicology, 2006, 99, 4
  27. 27
    Catherine Marcucci, Neil B. Sandson, Eric M. Thorn, Denis L. Bourke, Unrecognized Drug-Drug Interactions: A Cause of Intraoperative Cardiac Arrest?, Anesthesia & Analgesia, 2006, 102, 5, 1569

    CrossRef

  28. 28
    Karen T Hallam, James S Olver, Trevor R Norman, Effect of Sodium Valproate on Nocturnal Melatonin Sensitivity to Light in Healthy Volunteers, Neuropsychopharmacology, 2005,

    CrossRef

  29. 29
    M. Petracco, R. Viani, Espresso Coffee, 2005,

    CrossRef

  30. 30
    Pierre Baumann, Christoph Hiemke, Central Nervous System Drugs,